National Human Genome Research Institute; Notice of Meeting, 23035 [2024-07054]

Download as PDF lotter on DSK11XQN23PROD with NOTICES1 Federal Register / Vol. 89, No. 65 / Wednesday, April 3, 2024 / Notices Agenda: Break. Place: National Institute on Aging, Biomedical Research Center, 251 Bayview Blvd., Baltimore, MD 21224 (Hybrid). Closed: May 31, 2024, 11:45 a.m. to 1:00 p.m. Agenda: To review and evaluate executive Session Luncheon. Place: National Institute on Aging, Biomedical Research Center, 3A519/Virtual, 251 Bayview Blvd., Baltimore, MD 21224 (Hybrid). Closed: May 31, 2024, 1:00 p.m. to 1:15 p.m. Agenda: To review and evaluate laboratory/Branch Chief Leadership Overview (Lenore Launer, Ph.D., Laboratory Chief, Senior Investigator, LEPS). Place: National Institute on Aging, Biomedical Research Center, 251 Bayview Blvd., Baltimore, MD 21224 (Hybrid). Closed: May 31, 2024, 1:15 p.m. to 1:30 p.m. Agenda: To review and evaluate discussion with the Laboratory/Branch Chief. Place: National Institute on Aging, Biomedical Research Center, 251 Bayview Blvd., Baltimore, MD 21224 (Hybrid). Closed: May 31, 2024, 1:30 p.m. to 1:45 p.m. Agenda: To review and evaluate leadership Review Discussion. Place: National Institute on Aging, Biomedical Research Center, 251 Bayview Blvd., Baltimore, MD 21224 (Hybrid). Closed: May 31, 2024, 1:45 p.m. to 2:30 p.m. Agenda: To review and evaluate BSC members to meet with Fellows from LEPS. Place: National Institute on Aging, Biomedical Research Center, 251 Bayview Blvd., Baltimore, MD 21224 (Hybrid). Open: May 31, 2024, 2:30 p.m. to 2:45 p.m. Agenda: Break. Place: National Institute on Aging, Biomedical Research Center, 251 Bayview Blvd., Baltimore, MD 21224 (Hybrid). Open: May 31, 2024, 2:45 p.m. to 3:00 p.m. Agenda: Whole-genome sequencing in non-Alzheimer dementias: Progress, opportunities, and request for cloud resources (Concept) (Bryan J. Traynor, M.D., Ph.D., Senior Investigator, LNG). Place: National Institute on Aging, Biomedical Research Center, 251 Bayview Blvd., Baltimore, MD 21224 (Hybrid). Open: May 31, 2024, 3:00 p.m. to 3:15 p.m. Agenda: Discussion. Place: National Institute on Aging, Biomedical Research Center, 251 Bayview Blvd., Baltimore, MD 21224 (Hybrid). Closed: May 31, 2024, 3:15 p.m. to 4:30 p.m. Agenda: To review and evaluate executive Session (Final discussion of all Principal Investigators reviewed on all days.). Place: National Institute on Aging, Biomedical Research Center, 3C211/Virtual, 251 Bayview Blvd., Baltimore, MD 21224 (Hybrid). Closed: May 31, 2024, 4:30 p.m. to 4:30 p.m. Agenda: To review and evaluate adjourn. Place: National Institute on Aging, Biomedical Research Center, 3C211/Virtual, 251 Bayview Blvd., Baltimore, MD 21224 (Hybrid). VerDate Sep<11>2014 18:18 Apr 02, 2024 Jkt 262001 Contact Person: Luigi Ferrucci, M.D., Ph.D., Scientific Director, National Institute on Aging, 251 Bayview Boulevard, Suite 100, Room 4C225, Baltimore, MD 21224, 410– 558–8110, LF27Z@NIH.GOV. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: March 20, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–06980 Filed 4–2–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Council for Human Genome Research, NHGRI. This is a hybrid meeting held inperson and virtually and is open to the public as indicated below. Individuals who plan to attend in-person or view the virtual meeting and need special assistance or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from https://www.genome.gov/eventcalendar/102nd-Meeting-of-NationalAdvisory-Council-for-Human-GenomeResearch. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the intramural programs and projects, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council for Human Genome Research. Date: May 20–21, 2024. Closed: May 20, 2024, 9:00 a.m. to 10:00 a.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda, MD 20892 (Hybrid Meeting). PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 23035 Open: May 20, 2024, 10:30 a.m. to 6:00 p.m. Agenda: Report of Institute Director and Institute Staff. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda, MD 20892 (Hybrid Meeting). Closed: May 21, 2024, 9:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda, MD 20892 (Hybrid Meeting). Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review Officer, Scientific Review Branch, National Human Genome Research Institute, 6700B Rockledge Drive, Suite 3100, Rockville, MD 20892, (301) 402–0838, pozzattr@mail.nih.gov. Information is also available on the Institute’s/Center’s home page: https:// www.genome.gov/council, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: March 29, 2024. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–07054 Filed 4–2–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2024–0240] National Chemical Transportation Safety Advisory Committee; Vacancies United States Coast Guard, Department of Homeland Security. ACTION: Notice; request for applications. AGENCY: The U.S. Coast Guard is accepting applications to fill six vacancies on the National Chemical Transportation Safety Advisory Committee (Committee). This Committee advises the Secretary of Homeland Security, via the Commandant of the U.S. Coast Guard on matters relating to the safe and secure marine transportation of hazardous materials. SUMMARY: Completed applications must reach the U.S. Coast Guard on or before June 3, 2024. ADDRESSES: Applications must include: (a) a cover letter expressing interest in an appointment to the National Chemical Transportation Safety Advisory Committee, (b) a resume DATES: E:\FR\FM\03APN1.SGM 03APN1

Agencies

[Federal Register Volume 89, Number 65 (Wednesday, April 3, 2024)]
[Notices]
[Page 23035]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-07054]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Human Genome Research Institute; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Advisory 
Council for Human Genome Research, NHGRI.
    This is a hybrid meeting held in-person and virtually and is open 
to the public as indicated below. Individuals who plan to attend in-
person or view the virtual meeting and need special assistance or other 
reasonable accommodations, should notify the Contact Person listed 
below in advance of the meeting. The meeting will be videocast and can 
be accessed from https://www.genome.gov/event-calendar/102nd-Meeting-of-National-Advisory-Council-for-Human-Genome-Research.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the intramural programs and projects, the disclosure of 
which would constitute a clearly unwarranted invasion of personal 
privacy.

    Name of Committee: National Advisory Council for Human Genome 
Research.
    Date: May 20-21, 2024.
    Closed: May 20, 2024, 9:00 a.m. to 10:00 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda, 
MD 20892 (Hybrid Meeting).
    Open: May 20, 2024, 10:30 a.m. to 6:00 p.m.
    Agenda: Report of Institute Director and Institute Staff.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda, 
MD 20892 (Hybrid Meeting).
    Closed: May 21, 2024, 9:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda, 
MD 20892 (Hybrid Meeting).
    Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Human Genome Research 
Institute, 6700B Rockledge Drive, Suite 3100, Rockville, MD 20892, 
(301) 402-0838, [email protected].

    Information is also available on the Institute's/Center's home 
page: https://www.genome.gov/council, where an agenda and any 
additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human 
Genome Research, National Institutes of Health, HHS)

    Dated: March 29, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-07054 Filed 4-2-24; 8:45 am]
BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.